DALLAS, Oct. 8, 2008 (GLOBE NEWSWIRE) -- John Pentony, Publisher of StockGuru.com, announced today that the company has initiated profile coverage of PharmaCom BioVet, Inc. (Pink Sheets:PHMB). PharmaCom BioVet is dedicated to advancing the medical care industry for companion animals by establishing state-of-the-art treatment centers for lymphoma and other forms of cancer throughout the country. The purpose of these centers is to help prolong the quality of life for companion animals with cancer, and pursue the potential for a complete cure. These centers will also operate under the philosophy of providing a compassionate care environment for both the animal patients and their owners.
To view the StockGuru profile for PharmaCom BioVet, please visit:
http://www.stockguru.com/phmb.php
You may also visit the PharmaCom BioVet web site at:
http://www.PharmaComBioVet.com.
About StockGuru.com
StockGuru.com features daily alerts going out three times daily to members. To join our email alert list, please visit: http://www.stockguru.com/index.php?option=com_content&id=31&Itemid=5
To feature your publicly traded company in our alerts, or to discuss our complete services, please contact: John Pentony at (469) 252-3031 or email publisher@stockguru.com.
"Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements that are subject to risk and uncertainties, including, but not limited to, the impact of competitive products, product demand, market acceptance risks, fluctuations in operating results, political risk and other risks detailed from time to time in PharmaCom BioVet, Inc.'s filings with the Securities and Exchange Commission. These risks could cause PharmaCom BioVet, Inc.'s actual results to differ materially from those expressed in any forward-looking statements made by, or on behalf of, PharmaCom BioVet, Inc.
Disclosure: Pentony Enterprises LLC anticipates receiving a total of $16,000 cash and 1,500,000 free trading shares for profile coverage. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. It is the policy of Pentony Enterprises LLC to sell all shares of this and any company featured. Anyone considering any company we feature in consideration for free trading shares should consider this.